Gary Holland to Registries
This is a "connection" page, showing publications Gary Holland has written about Registries.
Connection Strength
0.182
-
Ophthalmic Immune-Related Adverse Events after Anti-CTLA-4 or PD-1 Therapy Recorded in the American Academy of Ophthalmology Intelligent Research in Sight Registry. Ophthalmology. 2021 06; 128(6):910-919.
Score: 0.163
-
A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study Group. Arch Ophthalmol. 1989 Dec; 107(12):1759-66.
Score: 0.019